Pfizer Heritage

Poised for Leadership in Biosimilars

Pfizer is a leader in biologics, with an established 30-year heritage in the development and manufacturing of these products. We're committed to re-innovating patient care by meeting unmet medical needs and advancing the standards of care with new biologic and biosimilar products.

Pfizer's commitment is backed by a solid infrastructure and expertise in biologics to support a global biosimilars business with:

  • Clinical development and regulatory expertise
  • Existing manufacturing capability and technology
  • An understanding of the needs of physicians, patients, and payers
  • Commercial scale to produce products that will offer treatment options to more than two-thirds of the world’s population

Pfizer is poised to be a natural leader in biosimilars production, with external biologics manufacturing sites in addition to an internal network managed through our external supply organization.

Pfizer has approved biologics in the therapeutic areas of:

  • Inflammation/Immunology
  • Hematology
  • Rheumatology
  • Neurology
  • Endocrinology
  • Ophthalmology

Our innovative core therapeutic areas of oncology and inflammation also align with what's central to our biosimilars pipeline.